Induction Healthcare Group PLC AIM Rule 17 Schedule 2(g) Update (5935G)
March 30 2022 - 6:00AM
UK Regulatory
TIDMINHC
RNS Number : 5935G
Induction Healthcare Group PLC
30 March 2022
30 March 2022
Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
AIM Rule 17 Schedule 2(g) Update
Induction (AIM: INHC), a leading virtual care platform driving
digital transformation of healthcare systems worldwide, announces
the following information relating to directors' disclosure under
Schedule Two, paragraph (g) of the AIM Rules for Companies:
Chris Spencer, non-executive Chairman, has been a director of a
private company, Acea Health Limited, since 2 April 2018. On 29
March 2022, Acea Health Limited entered into creditors voluntary
liquidation.
ENQUIRIES
Induction Via Walbrook PR Ltd: induction@walbrookpr.com
James Balmain, Chief Executive Officer
Guy Mitchell, Chief Financial Officer
Singer Capital Markets (Nominated
Adviser and Broker) +44 (0)20 7496 3000
Philip Davies / Kailey Aliyar
Walbrook PR Ltd induction@walbrookpr.com
Paul McManus / Stephanie Cuthbert Mob: +44(0)7980 541 893 / +44 (0)7796
794 663
About Induction - www.inductionhealthcare.com
Induction (AIM: INHC) Induction delivers a suite of software
solutions through a single integrated platform that transforms care
delivery. Our system-wide applications help healthcare providers
and administrators to deliver care at any stage remotely as well as
face-to-face - enabling a more flexible, efficient and positive
experience for the communities they serve . Purpose built for
integration with leading Electronic Medical Record (EMR) platforms,
our products offer immediate stand-alone value that becomes even
greater when integrated with pre-existing systems.
Used at scale by national and regional healthcare systems, as
well non-health government services, our applications are relied
upon by hundreds of thousands of clinicians and millions of
patients across almost every hospital in the British Isles.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCBKKBQCBKKCNN
(END) Dow Jones Newswires
March 30, 2022 06:00 ET (10:00 GMT)
Induction Healthcare (LSE:INHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Induction Healthcare (LSE:INHC)
Historical Stock Chart
From Jul 2023 to Jul 2024